Clinical Studies

Red Bank Veterinary Hospitals veterinarians and patients participate in a variety of clinical studies.

At Red Bank Veterinary Hospitals, our veterinarians participate in clinical studies initiated by our teams across a variety of medical specialties as well as studies in collaboration with other institutions.

Much is gained from participation in these studies: veterinarians obtain new techniques, treatments, and knowledge; and pets live longer, healthier lives through better care.

For additional information on current and pending clinical studies please see below or contact us at (732) 747-3636.

Current Clinical Studies

For information about current and pending clinical studies, or to refer one of your patients for consideration, please contact Red Bank Veterinary Hospitals at (732) 747-3636. A member of our team would be pleased to discuss whether an available study would benefit your patient.

*NOTE: Enrollment is closed for this study*

The use of cannabinoid derivatives in the treatment of a variety of neurological disorders in humans has recently been explored, particularly in the treatment of chronic pain and epilepsy. Full spectrum cannabinoid rich industrial hemp-based nutraceuticals (HBN) below 0.3% THC have been shown to have no psychotropic effects and modest activity through non-cannabinoid receptor routes affecting the serotonergic, glycinergic and GABA neurotransmission pathways that may be able to diminish pain, as well as inflammation.

Some patients will receive a placebo and regular pain medication post surgery. The other patients will get the hemp-derived nutraceutical in addition to the regular pain medication.

Read More

*NOTE: This study is not currently enrolling new patients until further notice*

The primary aim of the study is to assess the clinical responses of cats with naturally occurring mild to moderate chronic enteropathy when fed different types of dry kibble diets. As part of this study, three visits to Red Bank Veterinary Hospital in Tinton Falls are required for the patient. Owners must be willing to weigh the cat’s food daily for the entire 12 weeks. The owner will be required to complete a daily log of their cat’s habits for the duration of the study. The majority of the study is at no cost to the client.

Read More

The primary objective of this study is to determine the maximum tolerated dose, dose-limiting toxicities, safe starting dose, and pharmacodynamic effect of TANOVEA™ (rabacfosadine for injection) in cats with lymphoma, lymphoid leukemia or multiple myeloma/plasma cell tumor.

Read More

Pulmonic stenosis is a birth defect in the heart. It is caused by an incomplete pulmonary valve on the right side of the heart. It can result in serious, life-threatening changes in the way that the heart pumps blood. This study will aim to collect data on procedural technique of the corrective surgery.

Read More

*NOTE: This study is closed/manuscript in progress*

The aim of this study is to evaluate client perception of quality of life improvement in Labrador Retrievers with laryngeal paralysis (LP) given doxepin for one month compared to dogs given placebo.

Read More

Patent ductus arteriosus (also called PDA) is a birth defect in the heart. It is caused by incomplete changes in the heart’s circulation when a dog or cat is born. This results in serious, life-threatening changes in heart function and size. This study will aim to collect data on procedural technique of the corrective surgery.

Read More

The purpose of this trial is to evaluate the relevance of history and presentation in the evaluation of chronic valve disease in small breed dogs.

Read More

Lymphoma is one of the most common cancers in dogs. Current treatment options include various types of chemotherapy, including TANOVEA®-CA1 (rabacfosadine for injection), the first FDA conditionally approved drug to treat canine lymphoma. It is an intravenous chemotherapy agent that has been used both in normal dogs and in more than 600 dogs with cancer. The goal of this study is to evaluate the effectiveness and safety of rabacfosadine given once every 42 days alternating with doxorubicin given every 42 days.

Keep Reading

Types of Studies

Prospective studies are designed to evaluate existing treatments with larger numbers of patients for more meaningful evaluation or to assess new therapies not previously examined. New therapies may involve new protocols of previously used drugs or novel agents. Novel agents are considered experimental; however, the effectiveness of the treatment has been proven in laboratory animals. Safety for the novel agents has been demonstrated in normal dogs or cats, and, above all, the therapy is considered to be of potential benefit to the patient.


Patients that qualify and enter a prospective clinical study are monitored carefully, and strict adherence to the treatment protocol is necessary. Evaluation of the patient is dependent upon the study guidelines and generally involves visits to Red Bank Veterinary Hospitals.

Costs for Qualifying Patients

Costs vary depending on the study, however, for many prospective clinical studies, the costs of the staging, diagnosis, and therapy may be completely covered, or at least defrayed, by the specific study sponsor. The costs for each study can be found in the list above.

With owner permission, samples such as blood, urine, and tumor may be obtained to aid researchers in gaining additional information to benefit present and future patients.